![](/img/cover-not-exists.png)
Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study
Smolen, Josef S, Weinblatt, Michael E, van der Heijde, Désirée, Rigby, William F C, van Vollenhoven, Ronald, Bingham, Clifton O, Veenhuizen, Melissa, Gill, Anne, Zhao, Fangyi, Komocsar, Wendy J, BerclVolume:
74
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2014-207090
Date:
August, 2015
File:
PDF, 239 KB
english, 2015